drugset / Trial / NCT01714167
Autologous Bone Marrow Mesenchymal Stem Cell Transplantation for Chronic Stroke
Phase 1
Unknown
30 enrolled
Wenzhou Medical University
University of North Texas Health Science Center · collab
Non-randomizedParallel-groupOpen-labelTreatment
Summary
Stroke is one of the leading causes of disability in the world, and stem cell - transplantation provides a promising approach for rehabilitation. The main objective of this study is to evaluate the efficacy of the intracerebral injection of autologous bone marrow mesenchymal stem cells in patients with chronic stroke.
Timeline
- Start
- 2012-06
- Primary completion
- 2015-10
- Completion
- 2015-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | intracerebral stem cell transplantation | Cell therapy | 2e+06 cells | Other |
| Comparator | intracerebral stem cell transplantation | Cell therapy | 4e+06 cells | Other |